Brain, Vol. 125, No. 11, 2446-2459,
November 2002
© 2002 Oxford University Press
TNF-
reduces cerebral blood volume and disrupts tissue homeostasis via an endothelin- and TNFR2-dependent pathway
1 MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, Oxford, 2 CNS Inflammation Group, 3 Molecular Neuropathology Laboratory, School of Biological Sciences, University of Southampton, Southampton, UK, 4 Department of Pathology and Molecular Medicine and Centre for Gene Therapeutics, McMaster University, Hamilton, Ontario, Canada
Correspondence to: N. R. Sibson, MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, UK E-mail: niki{at}bioch.ox.ac.uk
TNF-
expression is elevated in a variety of neuropathologies, including multiple sclerosis, cerebral malaria and HIV encephalitis. However, the consequences of such high cerebral TNF- expression remain unresolved. Here, using MRI, we demonstrate that a focal intrastriatal injection of TNF- causes a significant, acute reduction (15–30%) in cerebral blood volume (CBV), which is dependent on TNF--type 2 receptor (TNFR2) activation, and can be ameliorated by pre-treatment with a non-specific endothelin (ET) receptor antagonist. An acute breakdown of the blood-cerebrospinal fluid barrier (B-CSF-B) and a delayed breakdown of the blood-brain barrier (BBB) were also observed using contrast-enhanced MRI. Furthermore, a significant reduction in tissue water diffusion was apparent 24 h after intrastriatal injection of TNF- injection, which may indicate compromise of tissue energy metabolism. Prolonged expression of endogenous TNF-, achieved through the use of an adenoviral vector expressing TNF- cDNA (Ad5TNF-m), caused a sustained depression in CBV in accordance with the single TNF- bolus data. These findings identify vasoconstriction, disrupted tissue homeostasis and damage to the BBBs as adverse effects of TNF- within the brain, and suggest that antagonists of the endothelin and TNF- type 2 receptors may be therapeutic in TNF--associated neuropathologies.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. J. du Plessis The Role of Systemic Hemodynamic Disturbances in Prematurity-Related Brain Injury J Child Neurol, September 1, 2009; 24(9): 1127 - 1140. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Serres, D. C. Anthony, Y. Jiang, K. A. Broom, S. J. Campbell, D. J. Tyler, S. I. van Kasteren, B. G. Davis, and N. R. Sibson Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain J. Neurosci., April 15, 2009; 29(15): 4820 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. S. Feng, D. J. Phillips, E. M. Stockx, V. Y. H. Yu, and A. M. Walker Endotoxin has acute and chronic effects on the cerebral circulation of fetal sheep Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R640 - R650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. I. van Kasteren, S. J. Campbell, S. Serres, D. C. Anthony, N. R. Sibson, and B. G. Davis Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease PNAS, January 6, 2009; 106(1): 18 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. S. Machado, M. S. Desruisseaux, Nagajyothi, R. P. Kennan, H. P. Hetherington, M. Wittner, L. M. Weiss, S. C. Lee, P. E. Scherer, M. Tsuji, et al. Endothelin in a Murine Model of Cerebral Malaria Exp Biol Med, June 1, 2006; 231(6): 1176 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Cheranov and J. H. Jaggar TNF-{alpha} dilates cerebral arteries via NAD(P)H oxidase-dependent Ca2+ spark activation Am J Physiol Cell Physiol, April 1, 2006; 290(4): C964 - C971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Campbell, V. H. Perry, F. J. Pitossi, A. G. Butchart, M. Chertoff, S. Waters, R. Dempster, and D. C. Anthony Central Nervous System Injury Triggers Hepatic CC and CXC Chemokine Expression that Is Associated with Leukocyte Mobilization and Recruitment to Both the Central Nervous System and the Liver Am. J. Pathol., May 1, 2005; 166(5): 1487 - 1497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Ferrari, A. M. Depino, F. Prada, N. Muraro, S. Campbell, O. Podhajcer, V. H. Perry, D. C. Anthony, and F. J. Pitossi Reversible Demyelination, Blood-Brain Barrier Breakdown, and Pronounced Neutrophil Recruitment Induced by Chronic IL-1 Expression in the Brain Am. J. Pathol., November 1, 2004; 165(5): 1827 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Rainero, L. M.E. Grimaldi, G. Salani, W. Valfre, C. Rivoiro, L. Savi, and L. Pinessi Association between the tumor necrosis factor-{alpha} -308 G/A gene polymorphism and migraine Neurology, January 13, 2004; 62(1): 141 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wuerfel, J. Bellmann-Strobl, P. Brunecker, O. Aktas, H. McFarland, A. Villringer, and F. Zipp Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study Brain, January 1, 2004; 127(1): 111 - 119. [Abstract] [Full Text] [PDF]
|
|